dr. bazhenova on sequencing beyond progression in egfr-mutant nsclc
Published 5 years ago • 65 plays • Length 1:58Download video MP4
Download video MP3
Similar videos
-
1:42
dr. bazhenova on sequential use of immunotherapy and egfr tkis in lung cancer
-
2:45
dr bazhenova on updated data from the trust-i trial of taletrectinib in ros1 nsclc
-
3:24
sequencing of therapies in egfr-mutant nsclc
-
2:50
sequencing with osimertinib in egfr-mutated nsclc
-
2:00
dr. bazhenova on new developments in ret-rearranged nsclc
-
9:58
how ngs inside hospitals transforms dna cancer cures
-
3:02
how a man’s 23andme test results saved dad’s life
-
3:58
current treatments and challenges for patients with egfr exon 20 insertion-positive nsclc
-
28:28
patient selection, therapeutic sequencing, & treatment selection in egfr mutation-positive nsclc
-
1:47
dr. clarke on combination approaches beyond progression on osimertinib in lung cancer
-
2:00
dr. goldberg on sequencing following treatment with osimertinib in nsclc
-
5:10
sequencing egfr-targeted therapies in nsclc
-
1:08
dr. bazhenova on the pacific trial with durvalumab in nsclc
-
13:06
genetics and genomics | 2024 living with egfr-mutant lung cancer patient forum
-
1:04
molecular testing in egfr mutant driven nsclc
-
2:50
optimizing therapy at progression of egfr-mutant nsclc
-
53:55
advancing care for patients with egfr mutation–positive nsclc: precision medicine strategies
-
8:31
resistance mechanisms and sequencing for egfr nsclc
-
1:08:18
next generation sequencing for egfr mutant lung cancer: how it guides treatment today & tomorrow
-
2:36
second- and third-generation tkis in egfr-mutated nsclc
-
2:19
dr. wakelee on detection of egfr t790m mutation in nsclc
-
32:15
a visual exploration of new targeted therapies for egfr exon 20 insertions in nsclc